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Risk Factors for Nosocomial Primary Bloodstream Infection
in Pediatric Intensive Care Unit Patients:
A 2-Year Prospective Cohort Study
Alexis M. Elward, MD; Victoria J. Fraser, MD
objective. The primary objective was to determine the rate of and risk factors for nosocomial primary bloodstream infection (BSI) in
pediatric intensive care unit (PICU) patients in order to determine the validity of our previously published findings. The secondary objective
was to analyze whether risk factors for primary BSI differed by organism type, particularly whether device use was more strongly associated
with BSI due to gram-positive organisms.
design. Prospective cohort study.
settings. St. Louis Children’s Hospital, a 235-bed academic tertiary care center with a 28-bed combined medical and surgical PICU.
patients. PICU patients admitted between September 1, 1999, and September 1, 2001.
outcome measures. Nosocomial primary BSIs.
results. Of 2,310 patients, 55% were male, and 73% were white. There were 124 episodes of primary BSI in 87 patients (3.8%).
Coagulase-negative Staphylococcus organisms were the leading cause of BSI (42 of 124 episodes). The rate of BSI was 9 BSIs/1,000 central
venous catheter–days. Multiple logistic regression analysis showed that independent predictors of nosocomial primary BSI included higher
number of arterial catheter–days (adjusted odds ratio [aOR], 5.7 per day of arterial catheterization; 95% confidence interval [CI], 3.4-9.8),
higher number of packed red blood cell transfusions (aOR, 1.2; 95% CI, 1.1-1.4), and genetic syndrome (aOR, 4.7; 95% CI, 1.8-12).
Severity of illness, underlying illnesses, and medications were not independently associated with increased risk of nosocomial BSI.
conclusion. Arterial catheter use and packed red blood cell transfusion are potentially modifiable risk factors for nosocomial primary
BSI in PICU patients. Genetic syndromes may be markers for unrecognized immune defects that impair host defense against microorganisms.
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Bloodstream infection (BSI) is the most frequent nosocomial
infection reported in pediatric intensive care unit (PICU)
patients.1-4 Central venous catheter (CVC)–associated BSI
rates in PICUs range from 7.7 to 46.9 infections per 1,000
CVC-days.4-9 These rates are comparable to BSI rates found
in burn units and neonatal intensive care units.6 Coagulase-
negative staphylococci are the most common pathogens iden-
tified among patients with catheter-related BSI (38% of ep-
isodes), although gram-negative rods are isolated in 25% of
PICU bacteremia cases.2 Several studies have shown an as-
sociation between BSI and mortality in PICU patients in uni-
variate analysis.3,4,10 The mean attributable cost of BSI in the
PICU ranges from $39,000 to $50,000 per patient.11-13
Several studies involving PICU patients have sought to
determine risk factors for nosocomial primary BSI.1,3,4,14,15
Longer duration of CVC use,3,14 increased number of CVCs
used,14 arterial catheter use,1,3 and receipt of extracorporeal
membrane oxygenation,14 dialysis,14 total parenteral nutri-
tion,3 and mechanical ventilation1,3 are each associated with
primary BSI. Some studies have been limited because of a
short duration of arterial catheterization among participants
and small sample size.
We performed a 2-year prospective cohort study to deter-
mine the rate of and risk factors for nosocomial BSI in PICU
patients in order to enlarge our study population and validate
the previously published analysis of data from the first 9
months of the study.4 In addition, we analyzed whether risk
factors for BSI due to gram-negative pathogens differed from
risk factors for BSI caused by coagulase-negative staphylo-
cocci, with the specific goal of determining whether device




This study was performed at St. Louis Children’s Hospital, a
235-bed teaching hospital affiliated with Washington Uni-
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versity School of Medicine (St. Louis). St. Louis Children’s
Hospital is located in the St. Louis metropolitan area and has
a referral base in southeastern Missouri and southwestern
Illinois with a 483-km (300-mile) radius. St. Louis Children’s
Hospital has a combined medical and surgical PICU with 22
beds. Six beds were added after construction of a new facility
in 2000. There are approximately 1,400 admissions to the
PICU per year. In the new facility, patient rooms are separated
by walls rather than curtains, and each room has a sliding
glass door and a sink placed next to the door. There were 12
sinks and 22 beds in the old facility.
Patients
Subjects for this study were patients admitted to the PICU
between September 1, 1999, and September 1, 2001. We ex-
cluded patients who were older than 18 years of age, who
died within 24 hours after admission, or who were from the
neonatal intensive care unit and receiving extra corporeal
membrane oxygenation in the PICU. Approval for this study
was obtained from the Washington University School of Med-
icine institutional review board. A waiver of written informed
consent was granted because of the observational nature of
this study.
Data Collection
All eligible study patients were monitored for the develop-
ment of nosocomial infection from the day of PICU ad-
mission until 48 hours after PICU discharge. Data on de-
mographic characteristics; underlying medical conditions;
surgeries and procedures performed; antibiotics, steroids,
stomach acid suppressants, and immunosuppressants re-
ceived; duration of hospital and PICU stays; PICU discharge
disposition; and durations of CVC, arterial catheter, and ven-
tilator use were collected from the medical records and daily
flow sheets. Severity of illness at PICU admission was cal-
culated using the Pediatric Risk of Mortality III (PRISM)
index. The PRISM score is weighted and was estimated on
the basis data on 17 physiological characteristics recorded
during the first 24 hours after PICU admission.16 Research
assistants were trained by the principal investigator (A.M.E.)
by means of written guidelines. Interrater reliability with a k
score of 0.7 or greater was required before independent data
collection occurred. PRISM scores for time points more than
24 hours after admission were obtained retrospectively by
review of patient flow sheets and laboratory results, using the
same written guidelines. Information on potential risk factors
was collected on all PICU patients during the study period.
There were no clusters of infection or outbreaks of infection
or colonization during the study period.
Definitions
Patients with more than 1 CVC placed simultaneously were
defined as having multiple CVCs. Transfusion data (ie, type
of blood product, date of administration, and amount re-
ceived) were obtained from the blood bank and from indi-
vidual medical records. Lung disease was defined as a history
of restrictive or obstructive pulmonary disease (including
asthma, bronchopulmonary dysplasia, and cystic fibrosis) or
chronic hypoxemia or hypercapnia requiring administration
of oxygen or mechanical ventilation at home, as documented
in the admission history and during physical examination.
Congenital heart disease was defined as abnormal cardiac
anatomy at birth, including an abnormal number of cham-
bers, an intracardiac shunt, or abnormally structured circu-
lation, valves, or coronary arteries. Developmental delay was
defined as a significant lag in development or an inability to
attain normal developmental milestones, and genetic syn-
drome was defined as a chromosomal abnormality or cluster
of physical findings consistent with a recognized genetic syn-
drome, as documented in the medical record. Transfusion
was defined as receipt of packed red blood cells, platelets,
fresh frozen plasma, or cryoprecipitate at any time during
the PICU stay. Transport out of the PICU was defined as
physical movement of the patient from the PICU to another
location, such as the operating room or radiology unit.
Only events that occurred before the development of nos-
ocomial BSI (ie, use of an arterial catheter and/or a CVC,
receipt of medication and/or total parenteral nutrition, trans-
port out of the PICU, and receipt of a transfusion) were
entered into the multiple logistic regression model as potential
risk factors for nosocomial primary BSI. The period of risk
was considered to be the duration of stay in the PICU.
Centers for Disease Control and Prevention definitions
were used to diagnose nosocomial primary BSIs.17 Primary
BSI was defined as infection that began 48 hours or more
after PICU admission and was due to bacteria or fungi in
the blood that were not present or incubating before hospital
admission. Patients without CVCs were eligible to receive a
diagnosis of primary BSI. All cases of BSI were incident cases.
Microorganisms causing BSIs were isolated by means of rou-
tine blood cultures, and their antibiotic susceptibility profiles
were obtained from microbiology laboratory reports. Coag-
ulase-negative Staphylococcus species were reported as a cause
of BSI only if 2 or more cultures of blood drawn on different
occasions yielded coagulase-negative Staphylococcus species.
Staphylococcal strains were not speciated. These criteria are
not definitive but were used in the attempt to distinguish
true infection from contamination. Only the first episode of
BSI was analyzed for children with more than 1 episode of
nosocomial BSI.
Data Analysis
SPSS, version 10 (SPSS), was used in statistical analyses. The
mean rate of nosocomial primary BSI was calculated as the
number of episodes of primary BSI divided by the number
of CVC- . Differences between mean values ofdays# 1,000
nonnormally distributed variables were analyzed by means of
the Mann-Whitney U test, and differences in the distribution
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of categorical variables were analyzed with the x2 test. All
statistical tests were 2-tailed. Because of the number of var-
iables examined for an association with nosocomial primary
BSI, a Bonferroni adjustment for multiple comparisons was
made to avoid spurious associations, and a P value of less
than .001 was considered to be statistically significant in uni-
variate analysis. Clinically relevant variables from univariate
analysis were used to create a logistic regression model to
assess the differences between patients with and patients with-
out BSI, with a P value of less than .1 as an entry criterion.
A forward stepwise model was used. Variables affecting less
than 10% of patients were not considered for entry into the
logistic regression model. Interaction effects between variables
that were statistically significant in multivariate analysis were
tested, and no significant interaction effects were found. The
fit of the model was evaluated using the Hosmer-Lemeshow
goodness-of-fit test. The multivariate analysis was performed
using the same methods involved in our previous analysis of
the first 9 months of data for this cohort.4
results
A total of 2,310 patients were enrolled in the study from
September 1999 through August 2001. Data on demographic
characteristics, underlying diseases, procedures, and medi-
cations are summarized in Table 1. There was a slight pre-
dominance of male patients and a marked predominance of
white patients. The mean age was 5.76 years (median age,
3.26 years). The mean PRISM score (SD) was 5.67
(median PRISM score, 4.00). The most common un-6.27
derlying diseases were congenital heart disease (in 29% of
patients) and lung disease (in 22% of patients), whereas burns
and congenital immunodeficiency were uncommon. A total
of 65% of patients were intubated. Thirty-four percent of
patients had a history of blood transfusion, 23% were treated
with steroids, and 29% received histamine type 2–receptor
blockers. Of the 795 patients who received a blood transfu-
sion, 38% received packed red blood cells, and 37% received
platelets; less commonly transfused were cryoprecipitate (in
19% of patients) and fresh frozen plasma (in 35% of patients).
There were 124 episodes of primary nosocomial BSI in 87
patients. The mean rate of primary BSI was 9 episodes/1,000
CVC-days. Patients with primary BSI had been in the PICU
for a mean duration (SD) of days (median13.4 11.51
duration, 10 days) before the development of primary BSI.
The microbiological characteristics of primary BSI for pa-
tients in the PICU are summarized in Table 2.
Results of univariate analysis comparing patients with and
patients without primary BSI are summarized in Table 1. This
comparison demonstrated an association between primary
BSI and each of the following underlying illnesses or con-
ditions: congenital heart disease, developmental delay, failure
to thrive, and genetic syndrome. Primary BSI was associated
with receipt of transfusion, transport out of the PICU, use
of a central line, use of multiple CVCs, use of an arterial
catheter, receipt of steroid therapy, and receipt of total par-
enteral nutrition. A total of 98% of arterial catheters were
placed peripherally in the radial artery.
To determine the association between organism type and
each potential risk factor, crude odds ratios (ORs) were cal-
culated, using uninfected patients as the comparison group. In
univariate analysis, patients with primary BSI due to gram-
negative organisms were associated with transfer from another
facility, congenital heart disease, failure to thrive, genetic syn-
drome, age of 30 days or less, receipt of total parenteral nu-
trition, receipt of prednisone, and receipt of any transfusion
(Table 3). Primary BSIs caused by coagulase-negative staphy-
lococcal species were also associated with each of these factors;
in addition, burns were associated with an increased risk of
BSI due to coagulase-negative Staphylococcus species (Table 3).
For gram-positive organisms other than coagulase-negative
Staphylococcus species (ie, for Staphylococcus aureus and En-
terococcus species), male sex and transplantation were associ-
ated with primary BSI. A comparison between patients with
BSI due to coagulase-negative Staphylococcus species and all
other patients with BSI revealed that only transfusion of packed
red blood cells was associated with an increased risk of BSI
due to coagulase-negative Staphylococcus species (crude OR,
3.37; 95% CI, 1.31-8.63; ).Pp .018
Multivariate analysis revealed that higher number of ar-
terial catheter–days, higher number of packed red blood cell
transfusions, and the presence of a genetic syndrome were
independent predictors of nosocomial primary BSI (Table 4).
Age and severity of illness at PICU admission did not in-
dependently predict nosocomial primary BSI.
Seven of the 26 patients with primary BSI and genetic syn-
drome had DiGeorge syndrome, 6 had Down syndrome, 4 had
defined chromosomal abnormalities (1 had associated con-
genital neutropenia, 1 had hypogammaglobulinemia, and the
other 2 had no recognized immunodeficiency), 1 had Turner
syndrome, 1 had Noonan syndrome, 5 had multiple congenital
anomalies with dysmorphic features (1 had polysplenia, and 1
had hypogammaglobulinemia), 1 had medium-chain fatty acid
deficiency, 1 had severe combined immunodeficiency, and 1
had Beckwith-Weidemann syndrome. Thus, only 13 of these
patients (50%) had recognized associated immunodeficiencies
that are possible risk factors for BSI.
discussion
We performed a 2-year prospective cohort study to determine
the rate of and independent risk factors for nosocomial BSI
in PICU patients in order to enlarge our study population
and validate our previously published analysis of the first 9
months of data.4 In addition, we analyzed whether risk factors
for BSI due to gram-negative pathogens differed from risk
factors for BSI caused by coagulase-negative staphylococci,
with the specific goal of determining whether use of an in-
vasive device was more strongly associated with BSI due to
gram-positive organisms. Multivariate analysis revealed that
table 1. Univariate Analysis of Factors Associated With Nosocomial Primary Bloodstream Infection (BSI) in







(n p 2,223) P
Age
Median y 3.3 0.6 3.45 !.001
Mean y  SD 5.8  6.0 … …
X30 d (neonate) 216 (9) 17 (20) 199 (9) .002
130 d but !1 y (infant) 549 (24) 36 (41) 513 (23) !.001
x1 y but !12 y (child) 1,062 (46) 25 (29) 1,037 (47) !.001a
x12 y (adolescent) 483 (21) 9 (10) 474 (21) !.001a
PRISM score
Median 4 … … .011
Mean  SD 5.67  6.27 … …
Race or ethnicity
White 1,696 (73) 68 (78) 1,628 (73)
African American 519 (22) 12 (14) 507 (23) .386
Other 95 (4) 7 (8) 88 (4)
Male sex 1,279 (55) 47 (52) 1,232 (56)
Underlying illness or condition .826
Failure to thrive 128 (6) 11 (13) 117 (5)
Lung disease 505 (22) 21 (24) 484 (22) .007
Genetic syndrome 387 (17) 26 (30) 361 (16) .598
Congenital heart disease 673 (29) 41 (47) 632 (28) !.001a
Invasive device use !.001a
Multiple central catheters 291 (13) 59 (68) 232 (10)
Central venous catheter 699 (30) 34 (39) 665 (30) !.001a
Arterial catheter 1,101 (48) 53 (61) 1,048 (47) .074
Mechanical ventilation 1,509 (65) 74 (85) 1,435 (65) .022
Surgery or procedure
Dialysis 55 (2) 13 (15) 42 (2) !.001a
Transplantation 143 (6) 13 (15) 130 (6) .001a
Cardiovascular surgery 460 (20) 26 (30) 434 (20) .002
Transfusion
History of transfusion 795 (34) 72 (83) 723 (33) .027
Packed RBCs transfused, U
Median 0 3 0
Mean  SD 0.7  3.6 7.4  13.1 0.4  2.2 !.001a
Location where procedures were performed
Outside of the hospital 137 (6) 6 (7) 131 (6) .642
Cardiac catheterization laboratory 82 (4) 11 (13) 71 (3) .007
Operating room 1,446 (63) 62 (71) 1,384 (62) .091
PICU 546 (24) 65 (75) 481 (22) .001a
Medication
Immunosuppressive agentsb 127 (5) 14 (16) 113 (5) !.001a
Histamine-2–receptor blockers 681 (29) 47 (54) 634 (29) !.001a
Steroids 546 (24) 34 (39) 512 (23) .003
Inotropes 588 (25) 47 (54) 541 (24) !.001a
Total parenteral nutrition 333 (14) 60 (69) 273 (12) !.001a
Other
Transferred from another facility 439 (19) 36 (41) 403 (18) !.001a
Transport out of the PICU 398 (17) 50 (57) 348 (16) !.001a
note. Data are no. (%) of patients, unless otherwise indicated. PRISM, Pediatric Risk of Mortality III.
a After the Bonferroni adjustment.
b For transplant recipients.
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table 2. Pathogens Causing Nosocomial Primary







Enterococcus species 18 (14.5)
Candida species 17 (14)
Staphylococcus aureus 9 (7.3)
Pseudomonas aeruginosa 9 (7.3)
Serratia marcescens 10 (8)
Klebsiella pneumoniae 6 (4.8)
Enterobacter species 8 (6.5)




note. CoNS, coagulase-negative Staphylococcus species.
increased number of arterial catheter-days, increased number
of packed red blood cell transfusions, and the presence of a
genetic syndrome were each independently associated with
an increased risk of nosocomial primary BSI in PICU patients.
In our previous analysis of the first 9 months of data from
this cohort, multivariate analysis revealed that use of multi-
ple CVCs, use of arterial catheters, invasive procedures per-
formed in the PICU, and transport out of the PICU were
independent predictors of nosocomial primary BSI.4 Methods
of data collection and statistical analysis did not change in
the interval between the 2 analyses. The previously published
interim analysis was reported to PICU nurses and physicians
as well as the hospital’s infection control and quality im-
provement departments, and a number of changes in policies
and procedures subsequently occurred, including creation of
an educational self-study module for nurses and physicians
that described the process of CVC care and placement of
physical barriers (ie, yellow tape and screens) around the
bedside of PICU patients receiving surgery at the bedside in
order to prevent unnecessary traffic through the area. In the
multivariate model, we examined the influence of a time
variable before and after reporting, as well as possible dif-
ferences between the first 9 months of the study (from Sep-
tember 1999 through May 2000) and the second part of the
study period (from June 2000 through September 2001) with
respect to the number of CVC-days, the number of arterial
catheter–days, transport out of the PICU, and the number
of invasive procedures performed in the PICU. We found no
significant differences between these 2 periods in the per-
centage of patients who underwent an invasive procedure in
the PICU, were transported out of the PICU, or had a genetic
syndrome. Arterial catheters were used by a slightly greater
percentage of patients during the second study period than
during the first period (49% vs 45%; ). There werePp .056
no significant differences in the percentage of patients with
CVCs between the 2 periods. However, mean duration (SD)
of CVC use was shorter during the second study period
( vs CVC-days; ), as was the mean3 2.9 7 5.7 Pp .043
duration (SD) of arterial catheterization ( vs3 3 0.6
arterial catheter–days; ). Transfusion was also3.5 Pp .001
slightly more common among patients during the second
study period (36% vs 32%; ). We conclude that thePp .015
findings of multivariate analysis involving a larger sample size
and a longer period are more robust and less subject to var-
iation in qualitative, unmeasured aspects of catheter care,
such as adherence to barrier precautions during catheter in-
sertion. The robustness of the findings for the larger sample
is supported by goodness-of-fit statistics from the multivar-
iate model.
In the 2-year cohort analysis, packed red blood cell trans-
fusion was more common among patients with BSIs caused
by coagulase-negative staphylococcal species, compared with
patients with BSIs caused by other organisms. Factors asso-
ciated with coagulase-negative staphylococcal BSIs were sim-
ilar to those associated with gram-negative bacterial BSIs.
Packed red blood cell transfusion and genetic syndrome have
not been previously described as risk factors for nosocomial
BSI in pediatric patients. In our previously published analysis,
patients with BSIs received transfusions more often than un-
infected patients, but the association did not hold in mul-
tivariate analysis.4
Arterial catheter use is a biologically plausible risk factor
for BSI, because such catheters are not always placed under
sterile conditions, they are accessed frequently, and they are
left in place for long periods because accessing arteries is
difficult in small patients. In addition, care of the arterial
catheter site is often not standardized. We noted a moderately
substantial effect size and a dose response, also supporting a
causal relationship. The finding that arterial catheter use in-
creases the risk of nosocomial primary BSI in PICU patients
contrasts with findings reported in the literature for adult
ICU patients. Several prospective studies involving adult ICU
patients demonstrated low rates of BSIs at catheter-related
insertion sites18 and showed that BSIs associated with arterial
catheters occurred in less than 1% of arterial catheters, with
rates of 1.5 BSIs/1,000 arterial catheter–days.19,20 In our PICU,
arterial catheters are left in place until they are no longer
indicated, they malfunction, or they become infected. This is
likely the practice in other PICUs, because children are small,
and accessing arteries is technically difficult. Only 2 pro-
spective studies of arterial catheter–related infections have
been performed in pediatric populations. Furfara et al.21
found that only 3% of 340 arterial catheters placed in PICU
patients were either locally infected or associated with BSI;
culture data were not available for 18% of catheters. Du-
charme et al.22 found no cases of local or systemic infection
associated with arterial catheters in 68 children. The current
rates of arterial catheter colonization warrant further study,
because advances in technology during the past 15 years may
have changed the composition of the PICU patient popula-
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table 3. Results of Univariate Analysis of Risk Factors for and Characteristics of Patients With Nos-






Risk factor, crude OR (95% CI)
Male sex NS NS 2.7 (1.1-6.8)
Transfer from another hospital 4.2 (2.0-8.8) 2.9 (1.3-6.8) 3.8 (1.6-8.8)
Congenital heart disease 2.4 (1.1-4.9) 4.7 (2.0-11.2) NS
Arterial catheter use 1.8 (0.9-3.9) 2.1 (0.9-5) 1.1 (0.5-2.6)
Central vascular catheter use 1.7 (0.8-3.5) 0.8 (0.7-2.1) 2.8 (1.2-6.5)
History of burns 21.3 (5.7-80) NS NS
Failure to thrive 2.9 (1.0-8.4) 3.8 (1.3-11.2) NS
Neonate status 3.2 (1.4-7.7) 2.8 (1.0-7.7) 3.0 (1.1-8.2)
Prednisone use 4.6 (2.5-8.5) 3.9 (2.1-7.0) 3.8 (2.1-6.8)
Total parenteral nutrition use 212 (59-757) 154 (38-622) 88 (18-419)
Transfusion
Packed RBCs 11.5 (5.4-24.3) 7.4 (3.2-17) NS
Platelets 11.9 (5.4-26.4) 12.1 (5.0-29.3) NS
Fresh frozen plasma 9.4 (4.0-21.8) 10.8 (4.3-26.8) NS
Cryoprecipitate NS 25.2 (9.8-65) 5.8 (1.3-25.5)
Characteristic, mean value  SD
Age, y 3.4 (6.0) 2.4 (4.2) 2.4 (5.0)
PRISM score 10.5 (8.2) 10.7 (8.8) 9.6 (7.5)
No. of arterial catheter–days 11.9 (13.7) 11.4 (13.4) 9.6 (13.8)
No. of CVC-days 10.7 (14.1) 11.9 (15.1) 10.7 (10.8)
note. Uninfected patients were used as the reference group. CI, confidence interval; CoNS, coagulase-negative
Staphylococcus species; CVC, central vascular catheter; NS, not significant; OR, odds ratio; PRISM, Pediatric Risk of
Mortality III; RBC, red blood cell.
table 4. Multivariate Analysis of Factors Associated With Nos-
ocomial Primary Bloodstream Infection (BSI) in a Pediatric Intensive
Care Unit
Risk factor aOR (95% CI) P
Genetic syndrome 4.7 (1.8-12) .001
High number of arterial catheter–days 5.7 (3.4-9.8) !.001
High number of packed RBC transfusions 1.2 (1.1-1.4) !.001
note. The final model had a x2 statistic of 529.574, a P value of less than
.001, a2log likelihood of 211.516, a Naegelkerke R
2 value of 0.747, a Hosmer-
Lemeshow goodness-of-fit statistic of 5.888 (with a P value of .660), and an
overall correct classification of 99.1% (78.2% for patients with BSI and 99.9%
for uninfected patients). aOR, adjusted odds ratio; CI, confidence interval;
RBC, red blood cell.
tion, such that more patients with complex congenital heart
disease, patients with genetic syndromes, and transplant re-
cipients are living longer. Arterial catheter use (as well as
packed red blood cell transfusion) may be a marker of on-
going severity of illness, and thus might be driving the as-
sociation between BSI and arterial line use through a different
mechanism. However, data on PRISM scores obtained closest
to the onset of BSI actually reveal that PRISM scores decrease
over time (mean admission PRISM score [SD] for patients
with BSI days [median, 8 days] vs mean PRISM10.2 8
score at infection [median, 5]; ). This6.4 6.3 P ! .001
makes it unlikely that ongoing severity of illness is driving
risk of infection through an undefined mechanism.
Transfusion of packed red blood cells is also a biologically
plausible risk factor for BSI, with several possible mechanisms
of BSI onset. Transfusion may be inherently immunosup-
pressive. Proposed mechanisms for this immunosuppressive
effect include the induction of suppressor T cells and anti-
idiotypic antibodies, deletion of naive T cells, and decreased
natural killer cell activity.23-29 Previous investigators have ob-
served that, in adult populations that have undergone car-
diovascular or colorectal surgery, the risk of surgical site in-
fection increases 7%-14% with each unit of packed red blood
cells transfused.23-29 Transfusion may also be a marker for
frequent access of arterial catheters and CVCs.
Finally, we identified genetic syndrome as a predictor of
nosocomial primary BSI. Patients with a genetic syndrome
may have recognized or unrecognized associated primary im-
munodeficiencies, placing them at increased risk for infection.
Half of our patients with a genetic syndrome had recognized
associated immunodeficiencies. Six of the 13 patients without
a documented immunodeficiency had Down syndrome. Pa-
tients with Down syndrome may have defects in humoral
immunity that predispose them to infection. Differences in
morbidity and mortality associated with nosocomial infection
that are based on single-nucleotide polymorphisms in the
promoter of the gene encoding TNF-a, in the gene encoding
TNF-b, and in the gene encoding cell marker CD14 (ie, the
lipopolysaccharide receptor) have been identified in adult
trauma patients.30-33 O’Keefe et al.32 demonstrated that pa-
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tients with single-nucleotide polymorphisms at the308 po-
sition in the TNF-a promoter have an OR of 2.5 for sepsis
after shock or organ failure and a 2-fold increased risk of
death. Majetschhak et al.33 demonstrated that homozygosity
for the TNF-b allele was associated with a 3-fold increased
risk for sepsis after shock or organ failure.
Our study had several limitations. PRISM scores were cre-
ated by research personnel. Other investigators have noted
wide variability in the generation of PRISM scores, particu-
larly when such scores are created by nonintensivists without
training.34 However, van Keulen et al.35 demonstrated that
training and use of written guidelines increased the consis-
tency of PRISM score determination among a group that
included nonintensivists, with intraclass correlation coeffi-
cients for nonintensivists of 0.24 before training and 0.73
after training. In addition, scores determined by the nonin-
tensivists correlated well with those determined by the in-
tensivists after training (intraclass correlation coefficient, 0.8).
We lacked a sufficient number of cases of BSIs due to gram-
positive organisms and cases due to gram-negative organisms
to perform multivariate analysis to determine independent
predictors for these infections. This sample size had a power
of 80% to detect a 10-fold difference in risk with a confidence
of 95%.
In summary, we found 2 independent risk factors for nos-
ocomial primary BSI in PICU patients that were related to
process of care, as well as a third risk factor unique to pediatric
patients that, to our knowledge, has not been previously re-
ported. Future interventions to decrease nosocomial primary
BSI rates among PICU patients should focus on improving
the process of arterial catheter care, as well as the processes
of CVC insertion and care. More studies are needed to test
the specific mechanisms by which transfusion and genetic
syndrome increase the risk of nosocomial primary BSI in
PICU patients.
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